Heparin prophylaxis has no benefit in medical patientsBMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e4940 (Published 31 July 2012) Cite this as: BMJ 2012;345:e4940
- Michael Snee, consultant in clinical oncology1
- 1Leeds Teaching Hospitals NHS Trust, St James’s Hospital, Leeds LS9 7TF, UK
The article on the introduction of methods to encourage or mandate the prescription of prophylaxis for venous thromboembolism (VTE) is misconceived.1 It is not true that most cases of deep vein thrombosis (DVT) in medical patients can be prevented. A recent meta-analysis found that symptomatic DVT occurred in 0.79% of patients given prophylaxis with heparin …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial